Fiducient Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$277K Buy
301
+1
+0.3% +$1.01K 0.04% 115
2025
Q4
$322K Hold
300
0.04% 139
2025
Q3
$229K Buy
300
+25
+9% +$18.6K 0.03% 143
2025
Q2
$214K Buy
+275
New +$214K 0.03% 145
2025
Q1
Sell
-308
Closed -$238K 162
2024
Q4
$238K Sell
308
-5
-2% -$4.14K 0.03% 133
2024
Q3
$277K Sell
313
-470
-60% -$423K 0.03% 123
2024
Q2
$710K Buy
783
+45
+6% +$36K 0.1% 79
2024
Q1
$574K Hold
738
0.11% 79
2023
Q4
$430K Buy
+738
New +$431K 0.08% 84

Other funds holding LLY

Fiducient Advisors's LLY Position: Q1 2026 in Review

Fiducient Advisors increased its Eli Lilly (LLY) stake by 0.33% in Q1 2026, buying an estimated $1.01K and bringing the position to 301 shares worth $277K. The position accounts for 0.04% of the portfolio, ranked #115.

Fiducient Advisors first reported a position in LLY in Q4 2023 and has held it in 9 quarters since. The position peaked at $710K in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Fiducient Advisors held 301 shares of Eli Lilly worth $277K as of Q1 2026.
  • Fiducient Advisors bought 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.04% of Fiducient Advisors's portfolio in Q1 2026, its #115 holding.
  • Fiducient Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 9 quarters since.
  • Fiducient Advisors's Eli Lilly position peaked at $710K in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fiducient Advisors's 13F filing for Q1 2026, filed 11 May 2026.